NanoString Technologies (NSTG) Stock Forecast & Price Prediction

Estimation of the future price movement of NanoString Technologies stock, based on various factors such as historical price trends, market trends, company performance, and economic conditions.

Price target

Current $0.59

Concensus $21.50

Low $15.00

Median $21.50

High $28.00

Based on analysts projections #NSTG is expected to experience a positive growth trajectory over the next year.

The current average NSTG price target, as estimated by these analysts, is $21.50.

The predictions for the future NSTG stock price range from a low of $15.00 to a high of $28.00, highlighting the variability of market expectations for NSTG.

It is important to note that market fluctuations and unforeseen events can have an impact on these projections, so investors should always exercise caution and conduct thorough research before making any investment decisions.

NSTG stock forecasts by analyst

Analyst / firm Date Rating Price target Price when posted
UBS February 2, 2023 Buy 15.00 11.99
Morgan Stanley August 8, 2022 Buy 28.00 15.50

NanoString Technologies (NSTG) Fundamentals Checker

Financial metrics are used to evaluate financial stability which helps analysts determine if NanoString Technologies is undervalued compared to its fair value. A company's financial health can strongly influence the stock forecast.


Financial Scores

Updated on: 07/12/2023

Altman Z-Score: -5.5

Piotroski Score: 3.0

ESG Score

Updated on: 07/12/2023

Environmental: 57.2

Social: 58.2

Governance: 56.9

Financial Health

Updated on: 07/12/2023

DCF: Strong Buy

ROE: Strong Sell

ROA: Sell

Debt to equity ratio: Strong Buy

Price to earnings ratio: Sell

Price to book ratio: Strong Buy

NSTG Discounted Cash Flow

Updated on: 07/12/2023

Discounted Cash Flow Value

Current Price

NSTG Revenues by Segment

Updated on: 07/12/2023


Revenue from Contract with Customer, Excluding Assessed Tax

NSTG Revenues by Region

Updated on: 07/12/2023

Asia Pacific

NSTG Notes Due

Updated on: 07/12/2023


There are no data to display

NanoString Technologies (NSTG) Social Sentiments

Monitoring bullish and bearish sentiments towards NanoString Technologies on Twitter and Stocktwits could help to forecast an upward or downward trend in NanoString Technologies stock price.

NanoString Technologies: A Powerful Stock Forecast in Biotech for Innovative Diagnostic Solutions

NanoString Technologies (NSTG) is a major company under the Medical Instruments & Supplies sector that specializes in biotechnology research and development. The firm has established itself as a pioneer in molecular diagnostics through the development of advanced technology platforms capable of detecting alterations in genes and proteins related to various diseases. NanoString's unique digital decoding technology allows for precise and...
The stock forecast of NanoString has been on an upward trajectory despite many challenges in the industry recently. Experts attribute the growth to remarkable financial results by the company alongside steady investments in aggressive growth initiatives. In 2023, revenue increased by almost 18%, reaching $133 million.

By staying on top of investors' minds with innovative diagnostic technologies, acquisitions, new market penetrations, strategic partnerships, and early-stage research collaborations paved the way to unprecedented success for NanoString Technologies. The company's commitment to uncovering new biomarkers for disease diagnosis and prognostication positions them as one of the best prospects in their field today.

Additionally, NanoString acquired two noteworthy firms: GeoMx Digital Spatial Profiler from Veracyte ($700 million deal), expanding their capacity for genomic analysis and immune profiling; and QIAGEN's dermatology franchise assets - providing access to a wide range of standard-of-care assays for oncology patients.

There is immense growth potential still visible pervading NanoString Technologies shares due to its robust business outlook moving forward. It remains an attractive investment prospect among biotech sector giants — a testament that continuous innovation and business versatility can triumph over pandemic turmoil or other unforeseen headwinds.

In conclusion, NanoString Technologies is a highly recommended stock candidate due to its cutting-edge solutions intended for groundbreaking medical treatment benefits. Their pioneering advancements in the field of molecular diagnostics demonstrate a highly innovative outlook with its leadership position assured for years to come. With this, investors are considering NanoString Technologies as a sound financial decision at present because of their impressive financial results, growing demand, and dynamic collaborations ultimately leading to sustained growth and astounding Stock Forecast outlook.">Read more